Volume 17, Issue 1 (7 2004)                   jdm 2004, 17(1): 12-18 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khoshkhoonejad A, Mohseni Salehi Monfared S, Hassanjani Roshan H. A comparison on the effect of 20mg Doxycycline versus placebo in the treatment of chronic periodontitis following scaling and root planning (SRP). jdm 2004; 17 (1) :12-18
URL: http://jdm.tums.ac.ir/article-1-377-en.html
Abstract:   (6869 Views)
Statement of Problem: Chronic periodontitis is one of the most prevalent periodontal diseases in the world which may be treated through surgical or non-surgical approaches.
Purpose: The aim of this study was to compare the efficacy of Doxycycline and placebo following SRP in non-surgical treatment of chronic periodontitis.
Materials and Methods: This double blind interventional study was conducted on patients attended to the periodontology department of Tehran faculty of dentistry from 2002 to 2003. After SRP, 22 cases and 23 controls were received Doxycycline and placebo, 20 mg twice a day for 3 months, respectively. Bleeding on probing (BOP), pocket depth (PD)<6mm and PD>7mm, and also clinical attachment level (CAL)<6mm and CAL>7mm in cases and controls after 3 and 6 months were compared by student t-test.Results: BOP after 3 and 6 months in Doxycycline recipients following SRP were significantly lower than in placebo recipients (P^0.007 and P=0.045 respectively). PD<6mm, PD>7mm, CAL<6mm and CAL>7mm in 3 and 6 months after SRP in cases were much lower than controls.
Conclusion: This study showed that the administration of Doxycycline for 3 months after SRP resulted in improvement of clinical indices as compared with SRP alone. Therefore, Doxycycline administration is recommended for chronic periodontitis treatment after SRP.
Full-Text [PDF 544 kb]   (1696 Downloads)    
Type of Study: Research | Subject: general
Published: 2013/08/7

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by: Yektaweb